Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 08:00:03 on US and Canada Markets.
2024-04-03 08:00:03 ET Scott Buck from H.C. Wainwright issued a price target of $2.50 for FPAY on 2024-04-03 06:07:00. The adjusted price target was set to $2.50. At the time of the announcement, FPAY was trading at $1.155. The overall price target consensus is at $4.00 ...
2024-04-03 08:00:03 ET Chris Caso from Wolfe Research issued a price target of $31.00 for INTC on 2024-04-03 06:04:00. The adjusted price target was set to $31.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
2024-04-03 08:00:03 ET Ruben Roy from Stifel Nicolaus issued a price target of $45.00 for INTC on 2024-04-03 06:08:00. The adjusted price target was set to $45.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
New York, NY, April 03, 2024 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the Video Experience Cloud, today announced that Kaltura Events has won Best Virtual Event Platform in North America in the 2024 Innovation in Business MarTech Awards . Kaltura Events enables organizers t...
LANDSEA HOMES NAMES MELISSA KELLY PRESIDENT OF DALLAS-FORT WORTH DIVISION PR Newswire Texas Homebuilding Executive to Oversee Region DALLAS , April 3, 2024 /PRNewswire/ -- Landsea Homes Corporation (Nasdaq: LSEA) ("Landsea Homes" or the "Company"...
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that do...
BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Tev...
ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the Annual Needh...
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“ Standard Uranium ” or the “ Company ”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to provide an update on exploration activities on the 19,604-hectare Sun...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
2.13%Change Percent:
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market: